推薦產品
等級
certified reference material
品質等級
形狀
liquid
包裝
ampule of 1 mL
製造商/商標名
Cerilliant®
drug control
Narcotic Licence Schedule B (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IIC (Portugal)
濃度
1 mg/mL in methanol
技術
gas chromatography (GC): suitable
liquid chromatography (LC): suitable
應用
forensics and toxicology
格式
single component solution
儲存溫度
2-8°C
SMILES 字串
CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
InChI
1S/C12H18N2O3/c1-4-6-8(3)12(7-5-2)9(15)13-11(17)14-10(12)16/h5,8H,2,4,6-7H2,1,3H3,(H2,13,14,15,16,17)
InChI 密鑰
KQPKPCNLIDLUMF-UHFFFAOYSA-N
基因資訊
human ... GABRA1(2554) , GABRA2(2555) , GABRA3(2556) , GABRA4(2557) , GABRA5(2558) , GABRA6(2559) , GABRB1(2560) , GABRB2(2561) , GABRB3(2562) , GABRD(2563) , GABRE(2564) , GABRG1(2565) , GABRG2(2566) , GABRG3(2567) , GABRP(2568) , GABRQ(55879)
一般說明
應用
- Barbiturate assay standardization: A research article presents a comprehensive protocol for high-throughput quantitative LC-MS/MS analysis of barbiturates, including Secobarbital, in human urine. This study is pivotal for clinical toxicology and forensic analysis, supporting accurate and efficient barbiturate detection (Gqamana and Zhang, 2024).
- Development of analytical techniques for Secobarbital: Another study details the specific analysis of Secobarbital in urine using LC-MS/MS. This research enhances the understanding of barbiturate metabolism and excretion, critical for both clinical and research settings (Campbell et al., 2024).
推薦產品
法律資訊
相關產品
訊號詞
Danger
危險分類
Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
標靶器官
Eyes
儲存類別代碼
3 - Flammable liquids
水污染物質分類(WGK)
WGK 1
閃點(°F)
49.5 °F - closed cup
閃點(°C)
9.7 °C - closed cup
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。
客戶也查看了
條款
HPLC Analysis of Barbiturates in Serum on Discovery® C18 after SPE using Discovery® DSC-18Lt
HPLC Analysis of Barbiturates in Serum on Discovery® C18 after SPE using Discovery® DSC-18Lt
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務